
About PharmSol
PharmSol is a Healthcare company based in Dubai (United Arab Emirates) founded in 2004. It offers pharmaceutical products, technologies, audits, and regulatory solutions globally. It operates on a B2B model. Its Indian entity Pharmsol India Private Limited reported revenue of βΉ2.26 Cr. PharmSol offers products and services including GMP/QP Audits, EUGMP Certification, Regulatory and Market Access, USFDA Compliance, and Biosimilar Support. Its focus areas include Pharmaceuticals, Product Development, Biosimilars and Regulatory Services.
Company details
PharmSol, established in 2004, is a global enterprise specializing in pharmaceutical products and tailored solutions. It delivers integrated services like GMP audits, regulatory compliance, and product development to clients worldwide. Operating through a network of manufacturers, it addresses challenges in regulations, engineering, and supply chains. With locations in Europe, Asia, and the Middle East, PharmSol ensures seamless access to its offerings for pharmaceutical companies.
- Headquarters Dubai, United Arab Emirates
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website pharm-sol.com
- Social LinkedIn X Facebook YouTube
- Legal Name Pharmsol India Private Limited
- Date of Incorporation 02 Sep, 2014
- Jurisdiction Madhapur Village, Telangana, India
- Indian entity revenue₹2.26 Cr
FY 2025 · -10% YoY
- Indian entity net profit₹2.1 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹16.9 Lakh
FY 2025 · 7% margin
Associated legal entities of PharmSol
PharmSol operates through Pharmsol India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharmsol India Private Limited CIN U74140TG2014PTC095488 | Active | 02 Sep 2014 | Hyderabad, Telangana | ₹2.3 Cr | 2 | View details |
Products & Services of PharmSol
PharmSol offers a comprehensive portfolio of products and services, including GMP/QP Audits, EUGMP Certification, Regulatory and Market Access, USFDA Compliance, and Biosimilar Support.
Conducts comprehensive audits for GMP compliance and quality assurance.
Provides tailored solutions for achieving EU GMP certification.
Offers integrated solutions for regulatory submissions and market entry.
Guides through USFDA inspections and regulatory requirements.
Delivers end-to-end support for biosimilar development and marketing.
Manages facility design and project commissioning for regulations.
Facilitates validated sources for pharmaceutical products and supplies.
Apps and channels of PharmSol
its YouTube channel PharmSol Group has 17 subscribers and 7 videos.
Videos from PharmSol
The most watched videos on PharmSol's YouTube channel, PharmSol Group (17 subscribers). Click a video to play it here.
More on PharmSol Group.
Board of directors of Pharmsol India Private Limited (PharmSol)
Pharmsol India Private Limited is the primary company behind PharmSol. The board of Pharmsol India Private Limited currently have 2 directors; the longest-serving is Sunil Kumar Shambhulal Doshi, appointed in 2016. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Kumar Shambhulal Doshi DIN 07393121 | Director | 22 Apr 2016 | 10 yrs 6 mo | Pharmsol India Private Limited |
| Srirengarajan Lakshminarasimhan DIN 09689084 | Director | 29 Jul 2022 | 4 yrs 2 mo | Pharmsol India Private Limited |
People of PharmSol
13 people are tracked at PharmSol (9 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership | |
Medarametla Rambabu | Vice President – Manufacturing | Leadership |
Shawn Xiao | Director - China, BD | Leadership |
Nancy Yao | Director - China, Technical Operations | Leadership |
S. Lakshminarasimhan | Executive Director | Leadership |
Ganesh Sangaiah | Director - New Drug Delivery Systems | Leadership |
Pradeep Vyas | Head-formulation Technology | Leadership |
Mamata Shettigar | Head Of Business Development | Leadership |
Arun Sehgal | Director – Strategic Business | Leadership |
Aditya Agarwala | Account Manager | Team |
Andrej Gasperlin | Senior Business Associate | Team |
Shahdad Moosa | Executive-business Process | Team |
Sai Praveen | Manager Product Development | Team |
Complete people profiles for PharmSol
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PharmSol
Figures of Pharmsol India Private Limited, the primary company behind PharmSol, for FY 2025. Revenue was ₹2.26 Cr (-10% year on year). Net profit was ₹2.1 Lakh (1% margin). EBITDA was ₹16.9 Lakh (7% margin). Revenue has grown at a compounded annual rate of +7% over three years and -2% over five years.
- ₹2.26 CrRevenue · FY 2025 · -10% YoY
- ₹2.1 LakhNet profit · 1% margin
- ₹16.9 LakhEBITDA · 7% margin
- ₹8.1 LakhPaid-up capital
- +7%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pharmsol India Private Limited are on its company page.
Detailed financial statements for PharmSol
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharmSol
PharmSol was founded in 2004.
PharmSol is headquartered in Dubai, United Arab Emirates. It is registered at Dubai, Dubai, United Arab Emirates.
The primary company behind PharmSol, Pharmsol India Private Limited, reported revenue of βΉ2.26 Cr for FY 2025, down 10% year on year.
PharmSol, established in 2004, is a global enterprise specializing in pharmaceutical products and tailored solutions. It delivers integrated services like GMP audits, regulatory compliance, and product development to clients worldwide. Operating through a network of manufacturers, it addresses challenges in regulations, engineering, and supply chains. With locations in Europe, Asia, and the Middle East, PharmSol ensures seamless access to its offerings for pharmaceutical companies.
PharmSol offers GMP/QP Audits, EUGMP Certification, Regulatory and Market Access, USFDA Compliance, and 3 more products and services.
PharmSol operates through Pharmsol India Private Limited.
The legal entities of PharmSol currently have 2 directors, including Srirengarajan Lakshminarasimhan, Sunil Kumar Shambhulal Doshi.